Form D · Other Technology
Kadia Health Corp.
New York, NY · CIK 0002036387
Offering snapshot reported Feb 19, 2026 · SEC filing
- Reported sold
- $1.1M Offering amount: $1.1M
- Investors reported
- 9 Form D · investor count
- Minimum accepted
- $1 Reported outside-investor minimum
- First sale
- Dec 16, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 19, 2026 | Initial | $1,100,000 | No comparison | 9 | SEC filing |
| Sep 10, 2024 | Initial | $45,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-573945
Source: Form D, filed Feb 19, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Charlotte Blais | Director, Executive |
Issuer details
Industry: Other Technology (See others in industry)
Address:
2248 Broadway #1684
New York, NY, 10024
New York, NY, 10024